GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LTS:0QLR) » Definitions » Inventories, Raw Materials & Components

Novartis AG (LTS:0QLR) Inventories, Raw Materials & Components : CHF0 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Novartis AG Inventories, Raw Materials & Components?

Novartis AG's inventories, raw materials & components for the quarter that ended in Sep. 2024 was CHF0 Mil.

Novartis AG's annual raw materials increased from Dec. 2021 (CHF801 Mil) to Dec. 2022 (CHF870 Mil) but then declined from Dec. 2022 (CHF870 Mil) to Dec. 2023 (CHF833 Mil).


Novartis AG Inventories, Raw Materials & Components Historical Data

The historical data trend for Novartis AG's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Inventories, Raw Materials & Components Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 737.93 859.08 801.27 870.11 832.80

Novartis AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 832.80 - - -

Novartis AG Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Novartis AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LTS:0QLR) » Definitions » Inventories, Raw Materials & Components
Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines